Related Experiment Video
Updated: Mar 25, 2026
03:53
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
Published on: December 29, 2023
1.4K
Tissue Factor: A Conventional or Alternative Target in Cancer Therapy
Andreas Eisenreich1, Juliane Bolbrinker2, Ulrike Leppert3
1Charité-Universitätsmedizin Berlin, CC04, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany; andreas.eisenreich@charite.de.
Clinical Chemistry
|February 21, 2016
Summary
Tissue factor (TF) plays a key role in cancer development. Targeting its two isoforms, full-length (fl)TF and alternatively spliced (as)TF, offers novel therapeutic strategies for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Tissue factor (TF) is a glycoprotein crucial in cancer pathogenesis.
- TF exists as two isoforms: membrane-bound full-length (fl)TF and soluble alternatively spliced (as)TF.
- Both TF isoforms influence tumor angiogenesis, thrombogenicity, growth, and metastasis.
Purpose of the Study:
- To review the latest findings on TF and its isoforms in cancer biology.
- To discuss the therapeutic potential of inhibiting TF activity and expression.
- To explore novel therapeutic options for cancer treatment targeting TF.
Main Methods:
- Literature review of current research on TF in cancer.
- Analysis of the roles of flTF and asTF in pathophysiological processes.
- Discussion of therapeutic strategies targeting TF and its signaling pathways.
Main Results:
- TF isoforms (flTF and asTF) have distinct roles in cancer.
- Isoform-specific signaling pathways mediate TF functions in thrombogenicity and angiogenesis.
- TF and its downstream signaling are implicated in malignant diseases.
Conclusions:
- Both asTF and flTF are significant in cancer biology, affecting key processes like thrombogenicity and angiogenesis.
- Isoform-specific signal transduction pathways are critical mediators of TF's role in cancer.
- Targeting TF isoforms and their downstream signaling presents promising therapeutic avenues for cancer.
Related Concept Videos
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:57Targeted Cancer Therapies
1.7K
1.7K
01:27Tumor Immunotherapy
2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.8K
02:17The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
02:38Mitogens and the Cell Cycle
8.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K